<DOC>
	<DOCNO>NCT01300390</DOCNO>
	<brief_summary>The overall hypothesis endothelial function , apolipoprotein level adiponectin level accurate predictor underlie cardiovascular disease patient end-stage liver disease , standard tool diagnosis screen cardiovascular disease limited utility .</brief_summary>
	<brief_title>Assessment Endothelial Function , Apolipoproteins Adiponectin</brief_title>
	<detailed_description>This study look use noninvasive test call reactive hyperemia peripheral artery tonometry ( RH-PAT ) check endothelial dysfunction . Endothelial dysfunction think indication future heart disease metabolic disorder . Adiponectin hormone associate heart disease . Apolipoprotein level , establish risk factor coronary artery disease general population . Our group would like see link endothelial function , adiponectin , apolipoprotein level posttransplant heart disease complication . The study would take result find new clinical procedure patient potentially high risk heart problem liver transplant procedure .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<criteria>Greater equal 21 year age . Cirrhotic endstage liver disease Pretransplant Dialysis shunt noncirrhotic liver disease fulminant hepatic failure</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>liver transplant</keyword>
	<keyword>end-stage liver disease</keyword>
	<keyword>cirrhosis</keyword>
</DOC>